학술논문
Rationale and design of a multicentre, 12-week, randomised, double-blind, placebo-controlled, parallel-group, investigator-initiated trial to investigate the efficacy and safety of elobixibat for chronic constipation
Document Type
Article
Author
Tanaka, K.; Kessoku, T.; Iwaki, M.; Fuyuki, A.; Yamamoto, A.; Takahashi, K.; Kasai, Y.; Ozaki, A.; Kobayashi, T.; Yoshihara, T.; Misawa, N.; Higurashi, T.; Hosono, K.; Yoneda, M.; Nakajima, A.; Kato, T.; Arimoto, J.; Chiba, H.; Sakai, E.; Iwasaki, T.; Kurihashi, T.; Nakatogawa, M.; Suzuki, A.; Taguri, M.; Oyamada, S.; Ariyoshi, K.; Kobayashi, N.; Ichikawa, Y.
Source
In: BMJ Open . (BMJ Open, 30 May 2022, 12(5))
Subject
Language
English
ISSN
20446055